HIE: Consumer engagement, state exchanges grow services

Beth Walsh - FOR LEAD ONLY - 195.12 Kb
Beth Walsh, Editor, CMIO
This month’s health information exchange (HIE) news includes a survey indicating patient engagement as a priority, and more developments among several states.

Consumer engagement is a top priority for U.S. HIEs with more than half (53 percent) of respondents ranking it as high or very high in their organization’s priorities, according to results of a survey of members of the National eHealth Collaborative's (NeHC) HIE Learning Network.

One-third of respondents said their strategies for consumer engagement with health IT are not clearly defined at all and 59 percent say their strategies for consumer engagement are beginning to evolve toward clarity. Eight percent consider their strategies to be very clearly defined.

Respondents named improve health outcomes, deliver information to patients and reduce healthcare costs among others as primary goals for consumer engagement with health IT.

The top ways that respondents to the survey are working toward patient engagement are delivering information electronically to patients, offering a patient portal and providing marketing or educational materials electronically.

Meanwhile, Massachusetts is the first state to receive approval for statewide HIE development through the Centers for Medicare & Medicaid Services (CMS). With $16.9 million in approved CMS funding, the state will complete the first phase of three, which involves organizing a project management team, developing a governance structure and selecting operations staff members.

And in Ohio, two primary care practices have successfully begun sharing immunization data with the Ohio Department of Health (ODH) through HIE. HealthBridge, a Cincinnati-based HIE that serves as a statewide health data hub, worked with the ODH Immunization Department on a pilot to electronically connect providers with the state immunization registry.

How are your HIE efforts coming along? Is interorperability starting to indicate some improvements in patient care? Please share your experience.

Beth Walsh
Editor, CMIO
bwalsh@trimedmedia.com

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.